Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 12 October (HL2877), what information they have received from the 15 companies who have submitted a proposal to the Antivirals Taskforce.

The companies who have contacted the Antivirals Taskforce have provided a wide range of information to inform the Taskforce on the antiviral/s that they are developing. This includes, but is not limited to, detail on the antiviral’s mechanism of action, available evidence from completed studies, target patient populations and route of administration. This information helps the Antivirals Taskforce to further expand understanding on the most promising antivirals being developed worldwide.